Skip to main content
. 2022 Jul 18;13:4154. doi: 10.1038/s41467-022-31839-7

Fig. 3. Vaccine Effectiveness against symptomatic and Severe COVID-19.

Fig. 3

According to days after booster dose during the Omicron dominance period, stratified by age group. Point estimates are adjusted vaccine effectiveness (1- adjusted odds ratio), with error bars indicating the corresponding 95% Wald’s C.I. Blue represents adjusted VE against symptomatic infection, and red adjusted VE against severe outcomes. All models the comparison group is unvaccinated.